Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Billing Codes

HCPCS Code B4197: Parenteral nutrition billing guide

Avatar photo Maja Popovska
Last Updated: August 17, 2026
Key takeaways

Key takeaways

HCPCS Code B4197 covers a compounded parenteral nutrition premix for patients who need 74 to 100 grams of protein per day, regardless of fluid volume.

B4197 claims route to the DME MAC, not the Part A or Part B MAC. Medicare Part B covers home parenteral nutrition only when GI tract dysfunction prevents adequate absorption.

CMS discontinued Certificates of Medical Necessity for dates of service on or after January 1, 2023. Medical necessity is now supported by a physician order, nutritional assessment, and diagnosis documentation retained in the medical record.

Pabau’s claims management software helps IV therapy and infusion practices automate documentation workflows, flag missing supporting documentation, and reduce B4197 claim denials before submission.

HCPCS Code B4197 is a compounded parenteral nutrition premix, billed for patients who need 74 to 100 grams of protein per day. The code is defined by that single protein-gram tier, not fluid volume or the number of bags administered.

Below 74 grams a day, the claim moves to B4193. Above 100 grams, it moves to B4199 instead.

This guide covers B4197’s code description, how it compares to adjacent B-series codes, and Medicare coverage rules. It also covers medical necessity criteria, 2026 fee schedule data, applicable modifiers, the ICD-10 crosswalk, and common billing errors.

B4197 full code description and key parameters

The official HCPCS Level II descriptor for B4197 is: Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 74 to 100 grams of protein – premix.

Breaking down every element of that descriptor matters for correct coding. The table below maps each component to its billing significance.

Component Descriptor Detail Billing Significance
Amino acids Compounded amino acid base Primary nitrogen/protein source; must be compounded per USP 797
Carbohydrates Dextrose component Energy substrate; concentration varies by patient metabolic need
Electrolytes Sodium, potassium, magnesium, phosphate, calcium Included in compounded bag; no separate billing for electrolytes in the base solution
Trace elements Zinc, copper, manganese, chromium, selenium Included in B4197; do not separately bill trace element additive codes
Vitamins Multivitamin infusion (MVI) additive Included in descriptor; MVI is bundled into the code
Protein tier 74 to 100 grams of protein per day Hard range; 73.9 g/day uses B4193, 100.1 g/day uses B4199
Unit of service One day’s supply of protein and carbohydrate Represents one day regardless of fluid volume or number of bags administered

Per CMS’s HCPCS code set, B4197 falls within the B-series covering enteral and parenteral nutrition supplies and solutions. The code is updated annually. Verify the current year’s descriptor against the official CMS HCPCS code file before billing.

How B4197 compares to adjacent parenteral nutrition codes

The B4189-B4199 premix series for parenteral nutrition is tiered strictly by grams of protein per day, not fluid volume or number of bags. One unit of service represents one day’s supply of protein and carbohydrate regardless of how that volume is delivered. Selecting the wrong protein tier is the single most common reason for B4197 claims to be denied or down-coded.

Code Protein (per day) Formulation Notes
B4189 10-51 g Premix Lowest protein tier in the premix series
B4193 52-73 g Premix Directly below B4197 in protein range
B4197 74-100 g Premix High protein tier – subject of this article
B4199 Over 100 g Premix Highest protein tier; most common upcoding error target

Coders should verify the patient’s compounding pharmacy order against the daily protein-gram total before selecting a code, regardless of fluid volume or number of bags. A prescription specifying 74 to 100 grams of protein per day maps to B4197. When the protein total rises above 100 grams per day, the claim should move to B4199 instead. B4164, B4168, B4172, B4176, B4178, and B4180 are separate homemix component codes for dextrose or amino-acid concentration, billed per 500 mL unit. They are not volume tiers of B4197, and shouldn’t be selected as alternatives to it. Use the AAPC HCPCS code lookup to cross-reference descriptor language when in doubt.

Medicare coverage for HCPCS B4197

Medicare Part B covers home parenteral nutrition when the beneficiary’s GI tract cannot be used to absorb nutrients adequately. This is the foundational coverage rule for IV therapy practices billing home parenteral nutrition. Because B4197 is a DMEPOS item, claims route to the DME MAC for the beneficiary’s jurisdiction, not the standard Part B MAC.

There are four DME MAC jurisdictions, administered by two contractors since a 2016 consolidation. Knowing which one handles a given claim determines where to send documentation and prior-authorization requests:

  • Jurisdiction A (CT, DC, DE, MA, MD, ME, NH, NJ, NY, PA, RI, VT): Noridian Healthcare Solutions
  • Jurisdiction B (IL, IN, KY, MI, MN, OH, WI): CGS Administrators
  • Jurisdiction C (AL, AR, CO, FL, GA, LA, MS, NC, NM, OK, PR, SC, TN, TX, USVI, VA, WV): CGS Administrators
  • Jurisdiction D (AK, AZ, CA, GU, HI, IA, ID, KS, MO, MT, ND, NE, NV, OR, SD, UT, WA, WY): Noridian Healthcare Solutions

Each DME MAC publishes its own Local Coverage Determinations (LCDs). The current LCD for parenteral nutrition is L38953, supported by Policy Article A58836. The prior LCD, L33798 (Policy Article A52515), was retired on November 12, 2020. Always verify the applicable LCD for the beneficiary’s jurisdiction before submitting. Per the CGS Medicare billing guidance, Medicare Part B covers home PN as a prosthetic device under the Medicare benefit, not as a drug benefit.

Billing supply codes accurately starts with inventory management software that knows what actually left the shelf.

Medical necessity criteria for B4197 claims

Meeting the protein threshold is necessary but not sufficient for B4197 coverage. The patient must also have a documented clinical condition that prevents adequate GI absorption. CMS and applicable LCDs define the following categories of qualifying diagnoses:

  • Massive small bowel resection: typically defined as retention of less than 5 feet of small intestine distal to the ligament of Treitz
  • Short bowel syndrome: insufficient absorptive surface area after surgery
  • Motility disorders: severe, clinically documented gastroparesis or intestinal pseudo-obstruction unresponsive to prokinetics
  • Bowel obstruction: partial or complete obstruction anticipated to last more than 3 months
  • Crohn’s disease or severe inflammatory bowel disease: where bowel rest is clinically required
  • Malabsorption syndromes: documented failure of enteral absorption via oral or tube feeding attempts
  • Radiation enteritis: where GI mucosa has been damaged and enteral nutrition is not feasible

A patient with any of these conditions who requires the 74-to-100-gram protein tier that defines B4197 meets the clinical threshold. The physician’s narrative in the medical record must connect the diagnosis to the inability to absorb nutrients enterally. Generic documentation such as “patient requires TPN” is insufficient.

Pro Tip

Document the failed enteral nutrition attempt before initiating home PN. LCDs in most jurisdictions require evidence that tube feeding was trialed and failed (or is contraindicated) before Medicare will cover parenteral nutrition. A brief notation in the physician’s note stating why enteral nutrition was not feasible is often the difference between approval and denial.

Documentation requirements for B4197 claims

Missing or incomplete documentation is the leading cause of B4197 denials. Every claim must be supported by a complete documentation package before the first infusion is billed. CMS discontinued Certificates of Medical Necessity (CMNs) and DME Information Forms (DIFs), including CMS-10126, for dates of service on or after January 1, 2023. The change is detailed in CMS Special Edition article SE22002. Suppliers must not submit a CMN or DIF with a current claim. Medical necessity is instead supported by documentation retained in the medical record and made available on request.

Required documents for B4197 Medicare claims:

  • Physician order / prescription: written order from the treating physician identifying the PN formulation, protein content, volume, and frequency
  • Nutritional assessment: completed by a registered dietitian or physician, documenting the patient’s caloric and protein requirements and the basis for the prescribed formulation
  • Diagnosis codes: ICD-10-CM codes supporting GI dysfunction and medical necessity (see ICD-10 crosswalk section below)
  • Medical records: history, physical examination, laboratory values (pre-albumin, albumin, weight), and documentation of failed or contraindicated enteral nutrition
  • Compounding pharmacy prescription: the actual compound order showing amino acid concentration, dextrose percentage, additive content, and daily volume

Practices using intake and consent forms can template the medical necessity documentation and nutritional assessment fields to ensure nothing is missed at the point of care. The IV therapy business guide typically includes setting up these documentation templates as part of the credentialing and billing setup process.

Customizable consent and intake forms
Pabau’s customizable intake and consent forms template medical necessity fields, so nothing is missed before a B4197 claim goes out.

B4197 fee schedule and Medicare allowable rates (2026)

Medicare payment rates for B4197 are established under the DMEPOS fee schedule, updated annually. Rates vary by whether the beneficiary’s area is rural or non-rural, using region-specific rates built from competitive bidding data, not the Physician Fee Schedule’s Geographic Practice Cost Indices (GPCI). The table below provides representative 2026 rate tiers. Actual payments depend on the beneficiary’s state and the applicable DMEPOS fee schedule modifier.

Rate Type Details How to Verify
National base rate Published annually in the CMS DMEPOS fee schedule files; expressed as per-day rate for B4197 CMS DMEPOS fee schedule tool (link below)
Geographic adjustment Rural and non-rural payment rates apply by region, built from competitive bidding data rather than GPCI Confirm rural/non-rural status and apply the correct DME MAC rate (link below)
Competitive bidding program Parenteral nutrition is statutorily excluded from the Competitive Bidding Program. CBP rates never apply to PN claims Not applicable. PN is exempt from competitive bidding regardless of the beneficiary’s ZIP code
Medicare cost-sharing Beneficiary pays 20% coinsurance after annual Part B deductible ($283 in 2026) Verify secondary/supplemental coverage before billing patient balance

Use the CMS DMEPOS fee schedule to retrieve the current-year allowable rate for B4197 by locality. Rates are expressed as per-day amounts. Multiply by days of service when billing a monthly supply. Verify current-year rates before submitting claims, as DMEPOS fee schedule amounts update every January 1.

Applicable modifiers for B4197

Modifier usage with B4197 depends on whether the claim involves a single-drug bag or a multi-drug parenteral nutrition bag. Most home PN formulations are multi-drug compounded solutions, which triggers the KO/KP/KQ modifier set. These modifiers apply when a single infusion bag contains two or more separately billed drugs. Every PN claim must also carry the KX modifier, confirming that the coverage criteria in the applicable LCD are met and documented.

Modifier Description When to Use with B4197
KO Single drug unit dose formulation per infusion bag When B4197 is the only drug in the bag; no additional separately-billed drugs are included
KP First drug in a multi-drug unit dose formulation per infusion bag Apply to the first code billed when the bag contains two or more separately-billed HCPCS drugs; B4197 is often the first-listed code
KQ Second or subsequent drug in a multi-drug unit dose formulation per infusion bag Apply to each additional drug code billed alongside B4197 in the same compound bag (e.g., lipid emulsion, additional additive codes)
KX Requirements specified in the medical policy have been met Append to every B4197 claim to attest that documentation supporting medical necessity, per the applicable LCD, is on file

KP/KQ modifier combinations for multi-drug compounded PN bags vary by scenario and aren’t always spelled out in national CMS manuals. Verify the applicable combination, plus the KX attestation, against your DME MAC’s local billing instructions before submitting.

ICD-10 codes that support medical necessity for B4197

Every B4197 claim must include ICD-10-CM diagnosis codes that directly support the medical necessity for home parenteral nutrition. The following codes are among those cited in CMS and LCD documentation as supporting medical necessity. This list is not exhaustive. Verify the complete list against the applicable jurisdiction’s LCD before billing.

ICD-10-CM Code Description Relevance to B4197
K91.2 Postsurgical malabsorption, not elsewhere classified Primary code for short bowel syndrome following resection
K50.00-K50.919 Crohn’s disease of small intestine / large intestine (range) When bowel rest is required and enteral feeding is not feasible
K31.84 Gastroparesis Severe motility disorder; document failed prokinetic treatment and enteral feeding attempts
K56.60-K56.699 Other and unspecified intestinal obstruction (range) When obstruction precludes enteral access and PN is required
K90.0 Celiac disease Severe refractory celiac with documented malabsorption
K90.3 Pancreatic steatorrhoea Pancreatic exocrine insufficiency with documented absorption failure
E43 Unspecified severe protein-calorie malnutrition Secondary code to document severity of malnutrition requiring high-protein PN formulation
K52.3 Indeterminate colitis Inflammatory bowel disease where bowel rest is required

Practices managing infusion patients can link ICD-10 diagnosis codes directly to treatment documentation through Pabau’s claims management software. It maps diagnosis codes to the corresponding HCPCS billing codes during the pre-submission review. For additional ICD-10 crosswalk guidance, the PGM Billing lookup tool provides free code search with diagnosis crosswalk functionality.

Automate claims and billing with Pabau
Pabau’s claims management software maps ICD-10 diagnosis codes to HCPCS billing codes automatically, so B4197 claims aren’t held up by mismatched documentation.

Common billing errors and how to avoid them

B4197 has a higher denial rate than many DMEPOS codes. Its narrow protein-gram tier and documentation requirements create multiple ways to select the wrong code or submit an incomplete claim. Practices billing mobile IV therapy should train billing staff on all of the following error patterns.

  • Confusing adjacent protein tiers: Coders round the daily protein total instead of checking the exact gram figure. A prescription of 100.5 grams of protein per day requires B4199, not B4197, even though the two codes look similar.
  • Submitting an outdated CMN or DIF: CMS discontinued Certificates of Medical Necessity and DME Information Forms for dates of service on or after January 1, 2023. Attaching one to a current claim can get it rejected or returned rather than approved.
  • No documentation of failed enteral nutrition: LCDs require evidence that enteral nutrition was tried and failed or is contraindicated. Missing this note is among the top denial triggers.
  • Incorrect DME MAC routing: Submitting a B4197 claim to the Part B MAC rather than the beneficiary’s DME MAC will result in rejection. Verify jurisdiction assignment before submission.
  • Modifier omission on multi-drug bags: Failing to append KP to the first drug code in a multi-drug compounded bag, or applying KQ without a corresponding KP, triggers edit-level rejections.
  • Missing the KX modifier: Home PN claims submitted without KX, which attests that LCD coverage criteria are met, are returned for correction or denied outright.
  • Billing frequency mismatches: B4197 is typically billed per day of service. Submitting a monthly total without units, or billing units as a lump sum, generates claim edits.
  • Unbundling additive codes incorrectly: Trace elements, vitamins, and electrolytes are included in the B4197 descriptor. Separately billing additive HCPCS codes for components already bundled into B4197 creates overpayment risk and audit exposure.

How Pabau streamlines B4197 billing and documentation

Compounded parenteral nutrition reimbursement depends on clean claims, and clean claims depend on documentation completed before the infusion starts. Most B4197 denials come from an incomplete record, not a coding mistake.

Before a B4197 claim goes out, Pabau can confirm the diagnosis code on file supports the HCPCS code selected. It also checks that modifier KP, KO, or KX is appended correctly. Recurring home PN claims follow documentation patterns similar to other IVF CPT codes.

This is the same workflow that EHR integration supports. The clinical record, the physician order, and the billing code all reference the same patient encounter. Practices using automated clinical workflows can set rule-based alerts when a parenteral nutrition order is missing required documentation, before the claim window opens.

Automated communication in Pabau
Pabau’s automated workflow alerts flag a parenteral nutrition order that’s missing required documentation before the claim window opens.

Pro Tip

Build a B4197 pre-billing checklist inside your practice management system: physician order dated within 12 months, nutritional assessment on file, diagnosis and ICD-10 code mapped, medical record documentation supporting necessity on file, modifier confirmed for bag type. Run this checklist before every claim cycle. Claims that clear the checklist have a substantially lower denial rate than those submitted without pre-validation.

Reduce HCPCS billing errors with Pabau

Pabau’s claims management tools help infusion and IV therapy practices automate documentation workflows, catch missing supporting documentation before submission, and track claim status across DME MAC jurisdictions.

Pabau claims management dashboard

Conclusion

Getting B4197 right comes down to one habit. Verify the daily protein-gram figure against the compounding pharmacy’s order before choosing the code, not after a denial arrives. Practices that build that check into intake, alongside the KX and bag-type modifiers, cut the code-selection errors that cause most DMEPOS denials.

The documentation side is harder to fix after the fact. A missing nutritional assessment or an undocumented failed enteral trial can’t be back-filled once a claim is under review. It has to be complete before the first infusion is billed.

Book a demo to see how Pabau helps infusion and IV therapy practices keep B4197 documentation and modifiers in order before a claim goes out.

Continue your research

Continue your research

Billing a different DME code? E0190 covers Medicare rules and fee schedule details for positioning cushions, another commonly denied DMEPOS item.

Need a dialysis billing comparison? A4725 walks through Medicare coverage and fee schedule rules for dialysate solution.

Placing central lines for PN administration? CPT 00532 covers anesthesia billing for central venous access procedures.

Treating patients with malabsorption? J2354 covers billing for octreotide, an injectable often used alongside parenteral nutrition.

Frequently asked questions

What does HCPCS Code B4197 cover?

HCPCS Code B4197 is a compounded parenteral nutrition premix for patients who need 74 to 100 grams of protein per day, regardless of fluid volume. It’s billed under Medicare Part B as a DMEPOS item for home parenteral nutrition when the patient’s GI tract can’t absorb nutrients adequately.

What is the Medicare reimbursement rate for B4197 in 2026?

The 2026 Medicare allowable rate for B4197 is published in the annual CMS DMEPOS fee schedule. Rates vary by whether the beneficiary’s area is rural or non-rural, not by the Physician Fee Schedule’s GPCI. Use the CMS DMEPOS fee schedule tool to look up the current rate. It updates every January 1.

How does B4197 differ from B4193 and B4199?

The B4189-B4199 premix series is tiered strictly by grams of protein per day, not fluid volume. B4193 covers 52 to 73 grams of protein per day, B4197 covers 74 to 100 grams, and B4199 covers anything over 100 grams. The key differentiator between B4197 and B4199 is the protein total. Crossing 100 grams per day moves the claim to B4199, regardless of fluid volume.

What documentation is required to bill B4197?

B4197 requires a written physician order specifying formulation and protein content, plus a nutritional assessment from a registered dietitian or physician. It also needs ICD-10-CM diagnosis codes supporting GI dysfunction and medical records documenting failed or contraindicated enteral nutrition. Finally, the compounding pharmacy prescription must show the actual compound ordered. CMS discontinued the Certificate of Medical Necessity for dates of service on or after January 1, 2023. This documentation must instead be retained in the medical record rather than submitted as a CMN. Failing to document why enteral nutrition was not feasible is among the top denial triggers.

Is B4197 covered under Medicare Part B or Part D?

B4197 is covered under Medicare Part B, not Part D. Home parenteral nutrition is classified as a prosthetic device under the Medicare benefit policy. It applies when the GI tract cannot be used and meets medical necessity criteria. Claims route to the DME MAC for the beneficiary’s geographic jurisdiction, not the standard Part B MAC or a Part D plan administrator.

Which DME MAC jurisdiction handles B4197 claims?

The DME MAC jurisdiction is determined by the beneficiary’s permanent address. Noridian Healthcare Solutions administers Jurisdictions A and D, and CGS Administrators handles Jurisdictions B and C. Each jurisdiction publishes its own Local Coverage Determination for parenteral nutrition, so verify the applicable LCD for the beneficiary’s state before submitting.

×